|
|
|
|
LEADER |
01514nam a2200337 u 4500 |
001 |
EB002001549 |
003 |
EBX01000000000000001164450 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
100 |
1 |
|
|a Ho, Chuong
|
245 |
0 |
0 |
|a Sentinel lymph node biopsy for the management of breast cancer
|h Elektronische Ressource
|b a review of guidelines
|c Chuong Ho, Charlene Argáez
|
250 |
|
|
|a Version 1.0
|
260 |
|
|
|a Ottawa
|b CADTH
|c April 24, 2019, 2019
|
300 |
|
|
|a 1 PDF file (15 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Canada
|
653 |
|
|
|a Neoplasm Staging / methods
|
653 |
|
|
|a Sentinel Lymph Node Biopsy / standards
|
653 |
|
|
|a Breast Neoplasms / therapy
|
653 |
|
|
|a Practice Guidelines as Topic
|
653 |
|
|
|a Breast Neoplasms / diagnosis
|
700 |
1 |
|
|a Argáez, Charlene
|e [author]
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK542754
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a This Rapid Response report aims to review the evidence-based guidelines associated with the use of sentinel lymph node biopsy for the management of breast cancer
|